Trending...
- EntryLevelActing.LA Website and Interview Published in Prep for Sat. HollywoodActorJobs.com Workshop - 139
- Class is in session: Black Beauty Block Party returns to Los Angeles for fourth annual festival - 111
- Governor Newsom signs legislation enacting long-recommended changes to improve TK-12 school governance in California - 105
FAYETTEVILLE, Ark. - Californer -- Lineus Medical, a leader in vascular access innovation and maker of SafeBreak® Vascular, the first breakaway device for IV lines, today announced the renewal of its agreement with Vizient, one of the nation's largest group purchasing organization (GPO). The renewed contract delivers more competitive pricing for Vizient members, expanding access to SafeBreak Vascular across health systems nationwide.
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on The Californer
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on The Californer
- Justplug Launches Grid-Independent Solar + Energy Resilience Service for California Estate Wineries
- California's Multi-Jurisdiction License Maze Is Getting Simpler in 2026
- FatWealth Why Fitness Coaching Clients Are Falling in Love with the FatWealth Asynchronous Coaching
- Governor Newsom signs DMV modernization law, expands mobile driver's license access for millions of Californians
- Governor Newsom extends business incentive program, bolstering California's nation-leading job creation
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
Source: Lineus Medical
0 Comments
Latest on The Californer
- RadioMobile Deploys IQ Fire Station Alerting System at Pleasant Hill Goshen Fire & Rescue
- Desna Therapeutics Receives SBIR Grant for Novel Immune Reprogramming Therapy in Type 1 Diabetes
- Search Is Broken. Curated Discovery Is the Future
- 20 Ways to Save Money Running a Van
- How Fortress Law Group Turned a DUI Arrest in Ohio Into a Full Acquittal at Trial
- Breaking the Silence: Tour Sparks National Conversation on Men's Mental Health and Domestic Abuse
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed
- Healthcare Organizations Shift Toward Integrated Growth Strategies as Leadership, Operations, and Te
- The Convergence of Healthcare, Construction, and Managed Services Organizations
- FatWealth - How FatWealth.com's Asynchronous Training Gives Fitness Coaches Their Life Back
- Salestrics Momentum Accelerates Following Fundraising Announcement and Orbit! Launch
- Salestrics Announces $1.5 Million SAFE Financing Round to Accelerate Growth
- LA Lemon Lawyer Provides Insight Into How Much Your Toyota Lemon Law Case May Worth in Los Angeles
- Hutchinson Joins Exclusive List of Top Authors with Twenty Plus Books in the Nation's Libraries
- Genni AI Launches AI Shopping Agent Built for Shopify Stores
- Able Rooter Expands Services to Offer Premium Water Heater Installation Across St. Louis
- Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home
- California: Paws on patrol: Governor Newsom announces six newly graduated K-9 teams to join CHP
- White Lion Bonding & Insurance Services Expands Guidance on Performance Bonds
- Serelora Acquires ACTIN Care Groups' Risk-Stratification Software


